Human Genome Sciences (HGSI) said yesterday it's reviewing its strategic options, including a...

This news story has 5 comments:

Register or Login to rate comments »

Dr. V Comments (1180)
 
They should take the $13 and get out now.

That is THE "strategic option" for HGS.

52 WK yo-yo is $6.51 - $30.00, stop the madness, take the $13 and lick the wounds, they will heal.
25 Apr 2012, 05:18 AM Reply Like

gostockyourself Comments (100)
 
im going to laugh when Glaxo buys DNDN instead and HGSI dwindles back down to $7.
25 Apr 2012, 07:52 AM Reply Like

j jenkins Comments (18)
 
You are dreaming Dundren has 0 compared to HGSI. Check your drug data.
26 Apr 2012, 03:05 PM Reply Like

j jenkins Comments (18)
 
HGSI is in charge here in the negotiations // with GSK not being able to make a buck on their own with the assets they have puts them in an absolutely NEEDS Human and better get the better offers out B4 someone else steps in and buys all their assets and starts turning a larger profit off of what they bring (Patented) to the table. Go HGSI(!!), you have earned an easy $20 a share in this sector or at least the equivalent in assets and cash. Buy your long calls now or else you'll miss out "Again".
26 Apr 2012, 03:05 PM Reply Like

j jenkins Comments (18)
 
1 day for me is like 10 days of experience for others, so my 5 years looks and feels and performs like 50 years of experience. When you figure in the advancements in technology in the last 5 years and what has happened OVER that Most Critical times of crisis in all the markets, local to global and change in administrations at Wash. DC. and congress trying to keep there ass together and everyone needs to vote out who EVER the incumbant is. We need a completely new presidential cabinet NOW as they are the ones making all the Kockamamie ideas that the "too busy with his family to run the country" Presidents death on tax deductions will be the end of his position and power to the people!!!!.
5 May 2012, 08:39 PM Reply Like